摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

<3,4-d>-Thienopyridazin | 270-84-8

中文名称
——
中文别名
——
英文名称
<3,4-d>-Thienopyridazin
英文别名
Thieno[3,4-d]pyridazine
<3,4-d>-Thienopyridazin化学式
CAS
270-84-8
化学式
C6H4N2S
mdl
——
分子量
136.177
InChiKey
XRYVPMFXAMWNMS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    358.2±15.0 °C(Predicted)
  • 密度:
    1.368±0.06 g/cm3(Predicted)
  • 熔点:
    182 °C

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    54
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    <3,4-d>-Thienopyridazin1-(triisopropylsiloxy)-1-hexyne 在 pyridinium bis(trifluoromethylsulfonyl)imide 作用下, 以 二氯甲烷 为溶剂, 反应 48.0h, 以81%的产率得到(2S,12S,13R)-12-butyl-5,16-dithia-1,9,10,20-tetrazapentacyclo[11.7.0.02,10.03,7.014,18]icosa-3,6,8,14,17,19-hexaen-11-one
    参考文献:
    名称:
    [2+2+2] 甲硅烷氧基炔烃与 1,2-二嗪的环加成反应:从反应发现到抗糖酵解化学型的鉴定
    摘要:
    未发现环加成反应:在温和的反应条件下,标题反应产生了高效且具有优异非对映选择性的新型多环化合物。使用该反应合成的小分子文库产生了一种新的化学型,该化学型通过阻断 CHO-K1 细胞中的葡萄糖摄取来抑制糖酵解 ATP 的产生。DMF= N,N-二甲基甲酰胺,Tf=三氟甲磺酰基,TIPS=三异丙基甲硅烷基。
    DOI:
    10.1002/anie.201305711
  • 作为产物:
    描述:
    噻吩-3,4-二甲醛一水合肼 作用下, 以 乙醇二氯甲烷 为溶剂, 反应 2.0h, 以86%的产率得到<3,4-d>-Thienopyridazin
    参考文献:
    名称:
    [2+2+2] 甲硅烷氧基炔烃与 1,2-二嗪的环加成反应:从反应发现到抗糖酵解化学型的鉴定
    摘要:
    未发现环加成反应:在温和的反应条件下,标题反应产生了高效且具有优异非对映选择性的新型多环化合物。使用该反应合成的小分子文库产生了一种新的化学型,该化学型通过阻断 CHO-K1 细胞中的葡萄糖摄取来抑制糖酵解 ATP 的产生。DMF= N,N-二甲基甲酰胺,Tf=三氟甲磺酰基,TIPS=三异丙基甲硅烷基。
    DOI:
    10.1002/anie.201305711
点击查看最新优质反应信息

文献信息

  • [EN] MONOBACTAMS AND METHODS OF THEIR SYNTHESIS AND USE<br/>[FR] MONOBACTAMES ET PROCÉDÉS DE SYNTHÈSE ET D'UTILISATION DE CES DERNIERS
    申请人:HARVARD COLLEGE
    公开号:WO2015103583A1
    公开(公告)日:2015-07-09
    Described herein are monobactam antibiotics of Formula (I), (Ι'), (II), and (II'), along with methods and intermediates for preparing these compounds. Pharmaceutical compositions and methods of treating infectious diseases using the monobactams are also provided.
    本文描述了单环内酰胺抗生素的化学式(I)、(Ι')、(II)和(II'),以及制备这些化合物的方法和中间体。还提供了使用单环内酰胺治疗传染病的药物组合物和方法。
  • Robba,M. et al., Bulletin de la Societe Chimique de France, 1967, p. 2495 - 2507
    作者:Robba,M. et al.
    DOI:——
    日期:——
  • Decroix,B. et al., Bulletin de la Societe Chimique de France, 1972, p. 3453 - 3462
    作者:Decroix,B. et al.
    DOI:——
    日期:——
  • Robba,M. et al., Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1964, vol. 259, p. 3783 - 3785
    作者:Robba,M. et al.
    DOI:——
    日期:——
  • MONOBACTAMS AND METHODS OF THEIR SYNTHESIS AND USE
    申请人:PRESIDENT AND FELLOWS OF HARVARD COLLEGE
    公开号:US20160326157A1
    公开(公告)日:2016-11-10
    Described herein are monobactam antibiotics of Formula (I), (I′), (II), and (II′), along with methods and intermediates for preparing these compounds. Pharmaceutical compositions and methods of treating infectious diseases using the monobactams are also provided.
查看更多

同类化合物

噻吩并[3,4-d]哒嗪-1-羧酸,5-氨基-3,4-二氢-3-(4-甲基苯基)-4-羰基-,乙基酯 1,4-二氯噻吩并[3,4-d]哒嗪 ethyl 5-[(4,4-dimethyl-2,6-dioxocyclohexylidenemethyl)amino]-4-oxo-3-phenyl-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate 5,7-Dimethyl-thieno<3,4-d>pyridazin ethyl 5-amino-3-(4-bromophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate ethyl 3-(3-chlorophenyl)-5-(N-methylacetamido)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate ethyl 5-amino-4-oxo-3-(4-(trifluoromethoxy)phenyl)-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate 5-amino-N-isopropyl-4-oxo-3-(4-(trifluoromethoxy)-phenyl)-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxamide 5-amino-4-oxo-3-(4-(trifluoromethoxy)phenyl)-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylic acid 5-amino-3-(4-chlorophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carbohydrazide ethyl 5-amino-3-(2-chlorophenyl)-4-oxo-3,4-dihydrothieno-[3,4-d]pyridazine-1-carboxylate 7-amino-2-(4-chlorophenyl)-4-methylthieno[3,4-d]pyridazin-1(2H)-one 7-amino-4-methylthieno[3,4-d]pyridazin-1(2H)-one ethyl 5-amino-3-(4-fluorophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate 7-amino-4-methyl-2-(pyridin-3-yl)thieno[3,4-d]pyridazin-1(2H)-one 7-amino-2-benzyl-4-methylthieno[3,4-d]pyridazin-1(2H)-one 7-amino-4-methyl-2-(2,2,2-trifluoroethyl)thieno[3,4-d]pyridazin-1(2H)-one 7-amino-4-methyl-2-(pyridin-2-yl)thieno[3,4-d]pyridazin-1(2H)-one N,N-dimethyl-N'-(7-methyl-4-oxo-3-p-tolyl-1-p-tolylazo-3,4-dihydrothieno[3,4-d]pyridazin-5-yl)-formamidine ethyl 5-amino-4-oxo-3-(o-tolyl)-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate 7-amino-2-isopropyl-4-methylthieno[3,4-d]pyridazin-1(2H)-one ethyl 5-amino-4-oxo-3-(4-(trifluoromethylsulfonyloxy)phenyl)-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate ethyl 5-amino-3-(4-bromophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate 5-amino-3-(4-chlorophenyl)-N-methyl-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxamide 5-amino-3-(4-chlorophenyl)-N,N-dimethyl-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxamide 5-amino-3,4-dihydro-3-p-tolylthieno<3,4-d>-pyridazin-1-carboxylic acid hydrazide 7-amino-2-cyclohexyl-4-methylthieno[3,4-d]pyridazin-1(2H)-one 5-amino-3-(4-hydroxyphenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylic acid ethyl 5-amino-3-(4-hydroxyphenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate 7-amino-2-p-tolyl-2H-thieno[3,4-d]pyridazin-1-one <3,4-d>-Thienopyridazin 5-amino-3-(3-chlorophenyl)-N-isopropyl-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxamide ethyl 5-amino-3-(3-chlorophenyl)-4-oxo-3,4-dihydrothieno-[3,4-d]pyridazine-1-carboxylate 5-amino-3-(3-chlorophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylic acid ethyl 5-(butylamino)-3-(3-chlorophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate butyl 5-(butylamino)-3-(3-chlorophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate ethyl 3-(3-chlorophenyl)-4-oxo-5-(2,2,2-trifluoroacetamido)-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate ethyl 5-((tert-butoxycarbonyl)amino)-3-(3-chlorophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate ethyl 5-(benzylamino)-3-(3-chlorophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate ethyl 3-(3-chlorophenyl)-5-(methylamino)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylate 5-amino-3-(4-bromophenyl)-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxylic acid 5-amino-3-(4-bromophenyl)-N-isopropyl-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxamide 5-amino-3-[4-(3-(18F)fluoranylpropoxy)phenyl]-4-oxo-N-propan-2-ylthieno[3,4-d]pyridazine-1-carboxamide tert-butyl N-[3-[4-(2-fluoroethoxy)phenyl]-4-oxo-1-(propan-2-ylcarbamoyl)thieno[3,4-d]pyridazin-5-yl]carbamate tert-butyl N-[3-(4-hydroxyphenyl)-4-oxo-1-(propan-2-ylcarbamoyl)thieno[3,4-d]pyridazin-5-yl]carbamate 5-amino-3-[4-(3-fluoro-2-hydroxypropoxy)phenyl]-4-oxo-N-propan-2-ylthieno[3,4-d]pyridazine-1-carboxamide Tert-butyl 5-amino-3-[4-(2-fluoroethoxy)phenyl]-4-oxothieno[3,4-d]pyridazine-1-carboxylate 5-amino-3-[4-(3-fluoropropoxy)phenyl]-4-oxo-N-propan-2-ylthieno[3,4-d]pyridazine-1-carboxamide 5-amino-3-[4-(2-(18F)fluoranylethoxy)phenyl]-4-oxo-N-propan-2-ylthieno[3,4-d]pyridazine-1-carboxamide 5-amino-3-(4-chlorophenyl)-N-cyclopropyl-4-oxo-3,4-dihydrothieno[3,4-d]pyridazine-1-carboxamide